Furthermore, the Nrf2 pathway activates CMA, inhibits α-synuclein accumulation, and alleviates rotenone-induced DAergic neuron degeneration, suggesting that the Nrf2 pathway orchestrates CMA, thereby alleviating neurodegeneration in PD [40]. This evidence concerns the gene SNCA and Parkinson disease.